Kevin Chung

Kevin Chung

Company: SeaStar Medical

Job title: Chief Medical Officer


The Selective Cytopheretic Device: A Novel Cell-directed Extracorporeal Therapy Targeting the Host-Response 9:30 am

Despite improvements in critical care medicine, acute kidney injury continues to cause high mortality rates in critically ill patients. AKI promotes a systemic inflammatory response resulting in microvascular damage and can lead to multi-organ dysfunction. This session will describe the processes of a dysregulated immune response, the mechanism of action of the novel selective cytopheretic…Read more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.